MD Anderson, Artios and ShangPharma have announced the in-licensing by Artios of a small-molecule ATR inhibitor program, developed jointly by MD Anderson and ShangPharma.Read more
Computational scientists, biophysicists and statisticians from Lawrence Livermore National Laboratory (LLNL) and Los Alamos National Laboratory (LANL) are leading a massive multi-institutional collaboration that has developed a machine learning-based simulation for next-generation supercomputers capable of modeling protein interactions and mutations that play a role in many forms of cancers.Read more
The AACI Public Policy Resource Library aims to enable cancer centers and partners in the cancer advocacy community to share resources to foster collaboration, promote cancer prevention, and spur the development of sound public health policy at the state and local level.Read more
It’s well known that exercise is good for preventing and treating many forms of heart disease, but less commonly known are the benefits of physical activity for people living with and beyond cancer.
A new initiative called Moving Through Cancer — led by Kathryn Schmitz, professor of public health sciences at Penn State College of Medicine, and an international team of health practitioners and researchers — is hoping to change that.
This grant will provide significant research funds for UTEP cancer scientists to understand better the molecular mechanisms, and possible environmental and lifestyle factors that contribute to this multifaceted disease.Read more
Seattle Children’s today announced the opening of Building Cure™, a new 540,000 square-foot pediatric research facility located at Stewart Street and Terry Avenue in downtown Seattle’s biotech corridor. Building Cure is the latest step in Seattle Children’s quest to revolutionize pediatric medicine and improve the lives of children worldwide.Read more
Roswell Park’s Dr. Clare Twist led an effort to develop and validate a new treatment algorithm for infants and children with neuroblastoma. In a new study in the Journal of Clinical Oncology, the team reports that many patients can safely receive less extensive therapy.Read more
In companion presentations at the American Society for Therapeutic Radiation Oncology Annual Meeting, doctors from Roswell Park Comprehensive Cancer Center report new evidence that low-dose aspirin and other anti-inflammatories may improve survival in patients with some head/neck and lung cancers.Read more
An oncogene, UPS21, has been confirmed as a frequently amplified gene in pancreatic ductal adenocarcinoma, the most common and often lethal form of pancreatic cancer. The discovery could lead to new treatment options.Read more
The American Society for Radiation Oncology (ASTRO) announced today the top-rated studies to be highlighted in the press program for the 2019 ASTRO Annual Meeting. Researchers will present their findings in three news briefings being held September 15 through 17 in room W474B of McCormick Place in Chicago and via live webcast.Read more
The National Cancer Institute (NCI) has designated Atlantic Health System as a National Community Oncology Research Program (NCORP) site of the Atlantic Health Cancer Consortium (AHCC). As New Jersey’s first and only NCORP, AHCC will help develop and implement NCI cancer prevention, care delivery, and treatment studies with leading healthcare systems across the state.Read more
A pair of Rutgers Cancer Institute of New Jersey physician-scientists are collaborating on national research projects that received $1.5 million in combined funding from the Oncology Research Information Exchange Network® (ORIEN) New Oncologic Visionary Awards (NOVA) program.Read more